Chao T Y, Hwang W S, Yeh M Y
Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China.
Proc Natl Sci Counc Repub China B. 1995 Apr;19(2):92-8.
A generation of lymphokine-activated killer (LAK) cell activities from malignant peritoneal effusions was investigated in 10 patients with abdominal carcinomatosis. Five of the 10 patients were victims of colorectal cancers, three of gastric cancers, and one each of ovarian cancer and cholangiocarcinoma. Lymphocytes, the so-called effusion associated lymphocytes (EALs), were isolated from malignant peritoneal effusions by density gradient centrifugation and the plastic adherence method. These isolated EALs were subsequently cultured in the presence of recombinant interleukin-2(rIL-2), 3,000 I.U./ml, for 30 days. Natural killer (NK) cell activities and LAK cell activities of the freshly isolated and cultured EALs were examined at 0, 7, 14, and 30 days of culture by means of a standard 51Cr-release assay using K-562, HL-60, and autologous tumor cells as target cells. The NK cell activities of the freshly isolated EALs were not detected in any of the 10 patients. The LAK activities, however, could be generated in all of them, and the activities were maximal at 7 days. The longer the EALs remained in the culture, the weaker were the LAK cell activities. As far as cell growth was concerned, EALs proliferated well as long as the rIL-2 were present in the culture. Phenotypic analysis of the freshly isolated EALs revealed the presence of NK cells (22%, CD16+CD56+), T helper/inducer (18%, CD4+), T cytotoxic/suppressor (50%, CD8+), and B cells (8%, CD19+). After being cultured with rIL-2, the B lymphocytes gradually disappeared, and the T lymphocytes predominated with an increase in the percentage of T helper/inducer cells.(ABSTRACT TRUNCATED AT 250 WORDS)
对10例腹部癌转移患者的恶性腹腔积液中产生的一代淋巴因子激活的杀伤(LAK)细胞活性进行了研究。10例患者中,5例为结直肠癌患者,3例为胃癌患者,1例为卵巢癌患者,1例为胆管癌患者。通过密度梯度离心和塑料贴壁法从恶性腹腔积液中分离出淋巴细胞,即所谓的积液相关淋巴细胞(EAL)。随后将这些分离的EAL在3000国际单位/毫升的重组白细胞介素-2(rIL-2)存在下培养30天。在培养的第0、7、14和30天,通过使用K-562、HL-60和自体肿瘤细胞作为靶细胞的标准51Cr释放试验,检测新鲜分离和培养的EAL的自然杀伤(NK)细胞活性和LAK细胞活性。在10例患者中,任何一例新鲜分离的EAL均未检测到NK细胞活性。然而,所有患者均可产生LAK活性,且在第7天活性最高。EAL在培养中停留的时间越长,LAK细胞活性越弱。就细胞生长而言,只要培养中有rIL-2,EAL就能良好增殖。对新鲜分离的EAL进行表型分析,发现存在NK细胞(22%,CD16+CD56+)、T辅助/诱导细胞(18%,CD4+)、T细胞毒性/抑制细胞(50%,CD8+)和B细胞(8%,CD19+)。用rIL-2培养后,B淋巴细胞逐渐消失,T淋巴细胞占主导,T辅助/诱导细胞百分比增加。(摘要截短于250字)